5-AMINO-1MQ 50mg

5-Amino-1MQ is a research chemical (not actually a peptide) that is being explored for its potential effects on fat loss, metabolism, and cellular energy. It works by inhibiting an enzyme called NNMT (nicotinamide N-methyltransferase), which plays a role in how the body stores fat and uses energy. By blocking this enzyme, the compound may help increase NAD+ levels, a molecule important for energy production and cellular function.

Because of this mechanism, it is often marketed in fitness and biohacking spaces as a non-stimulant fat-loss or metabolic enhancer, different from typical fat burners that rely on caffeine or appetite suppression. Early animal and lab studies suggest it may reduce fat mass, improve insulin sensitivity, and support better energy metabolism.

However, the most important point is that 5-Amino-1MQ has no human clinical trial data. It has not been approved for medical use, and its safety, effectiveness, and proper dosing in humans are still unknown.

Typical products labeled “50 mg” refer to the amount per capsule or dose, often within a commonly discussed research range (around 50–75 mg daily), but this is not an officially established or safe dosage guideline.

In terms of side effects, short-term reports suggest mostly mild issues like nausea, headaches, or digestive discomfort, but the bigger concern is the lack of long-term safety data, including possible effects on metabolism, hormones, or even cancer-related pathways.